Alvotech ALVO

NAS: ALVO | ISIN: LU2458332611 17/07/2026

3,460 USD (+2,67%)

(+2,67%) 17/07/2026

Grafiek Alvotech

Grafiek Alvotech

1 dag1d 2,67%
1 week1w 2,37%
1 maand1m -5,21%
3 maanden3m -4,42%
6 maanden6m -30,24%
1 jaar1j -59,95%
5 jaar5j -69,08%

Alvotech in het nieuws

Toon enkel gratis nieuws

3 juli 2026 · Transactions of Managers and Closely Associated Persons · Persbericht

1 juli 2026 · Alvotech further strengthens liquidity by securing term loan facility of $75 million · Persbericht

23 juni 2026 · Transactions of Managers and Closely Associated Persons · Persbericht

18 juni 2026 · Alvotech Announces Closing of Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares, Raising an Aggregate of $165 Million with Concurrent Private Placement · Persbericht

16 juni 2026 · Alvotech Announces Pricing of $152 Million Public Offering of Ordinary Shares and Concurrent Private Placement · Persbericht

15 juni 2026 · Alvotech Announces Proposed $125 Million Public Offering and Concurrent Private Placement of Ordinary Shares · Persbericht

10 juni 2026 · Transactions of Managers and Closely Associated Persons · Persbericht

8 juni 2026 · Alvotech announces FDA acceptance of Biologics License Application for AVT16, a proposed interchangeable biosimilar to Entyvio® · Persbericht

4 juni 2026 · Alvotech announces resubmission of U.S. Biologics License Applications for AVT05, a proposed biosimilar to Simponi® and Simponi Aria®, and AVT06, a proposed biosimilar to Eylea® · Persbericht

3 juni 2026 · Main Results of 2026 Annual and Extraordinary General Meeting · Persbericht

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe